TOMSICEK MICHAEL JOHN
Insider CIK 1570392 · MIST Director · CRSP Chief Financial Officer · ACRV Director · ABMD Vice President, CFO · CBST SVP & Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 20,275 | — | $0 | 20,275 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-05-18 | 2026-05-20 | 9,366 | — | $0 | 9,366 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-06-13 | 2025-06-17 | 20,275 | — | $0 | 20,275 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2024-08-28 | 2024-08-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 20,275 | — | $0 | 20,275 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2023-06-07 | 2023-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2022-11-14 | 2022-11-16 | 35,235 | — | $0 | 35,235 | SEC↗ |
| MIST Milestone Pharmaceuticals | P Buy | 2022-10-19 | 2022-10-21 | 15,000 | $5.32 | $79.8K | 15,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2022-07-05 | 2022-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-08-06 | 2021-08-10 | 5,989 | $139.46 | $835.2K | 1,891 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-08-06 | 2021-08-10 | 19,011 | $138.22 | $2.63M | 7,880 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-08-06 | 2021-08-10 | 25,000 | $17.75 | $443.8K | 26,891 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-03-11 | 2021-08-10 | 25,000 | — | $0 | 131,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-03-11 | 2021-03-12 | 25,360 | — | $0 | 25,360 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-03-11 | 2021-03-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-10 | 2021-03-12 | 2,833 | — | $0 | 3,243 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-03-10 | 2021-03-12 | 1,352 | $124.15 | $167.9K | 1,891 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-10-05 | 2020-10-06 | 11,666 | — | $0 | 11,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-09-01 | 2020-09-03 | 12,000 | — | $0 | 156,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-09-01 | 2020-09-03 | 6,400 | $92.23 | $590.3K | 3,210 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-09-01 | 2020-09-03 | 12,000 | $17.75 | $213.0K | 12,410 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-09-01 | 2020-09-03 | 2,800 | $93.18 | $260.9K | 410 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-09-01 | 2020-09-03 | 2,800 | $91.39 | $255.9K | 9,610 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-08-03 | 2020-08-05 | 6,552 | $86.25 | $565.1K | 5,858 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-08-03 | 2020-08-05 | 5,448 | $87.33 | $475.8K | 410 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-08-03 | 2020-08-05 | 12,000 | $17.75 | $213.0K | 12,410 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2020-06-05 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-03-10 | 2020-03-12 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-03-10 | 2020-03-12 | 8,500 | — | $0 | 8,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-12-03 | 2019-12-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-03-05 | 2019-03-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-06-15 | 2018-06-15 | 20,760 | — | $0 | 20,760 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-03-07 | 2018-03-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-11-13 | 2020-08-05 | 12,000 | — | $0 | 168,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2017-11-13 | 2017-11-14 | 180,000 | — | $0 | 180,000 | SEC↗ |
| ABMD ABIOMED INC | F Tax w/h | 2017-07-15 | 2017-07-18 | 3,925 | $145.07 | $569.4K | 27,081 | SEC↗ |
| ABMD ABIOMED INC | F Tax w/h | 2017-05-24 | 2017-05-26 | 1,567 | $134.74 | $211.1K | 34,931 | SEC↗ |
| ABMD ABIOMED INC | A Award deriv | 2017-05-15 | 2017-05-17 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ABMD ABIOMED INC | A Award | 2017-05-15 | 2017-05-17 | 8,198 | — | $0 | 34,998 | SEC↗ |
| ABMD ABIOMED INC | A Award | 2017-05-15 | 2017-05-17 | 1,500 | — | $0 | 36,498 | SEC↗ |
| ABMD ABIOMED INC | A Award deriv | 2016-05-24 | 2016-05-26 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ABMD ABIOMED INC | A Award | 2016-05-24 | 2016-05-26 | 1,800 | — | $0 | 26,800 | SEC↗ |
| ABMD ABIOMED INC | A Award deriv | 2015-07-15 | 2016-05-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ABMD ABIOMED INC | A Award deriv | 2015-07-15 | 2015-07-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ABMD ABIOMED INC | A Award | 2015-07-15 | 2015-07-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 17,233 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 4,085 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 31,559 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 4,365 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 4,029 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 1,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 5,875 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 10,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 1,667 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 15,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 2,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 18,404 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 3,004 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 2,253 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 1,199 | $102.00 | $122.3K | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 14,765 | $102.00 | $1.51M | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-12-29 | 2014-12-31 | 20,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | F Tax w/h | 2014-12-29 | 2014-12-31 | 11,367 | $100.71 | $1.14M | 14,765 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-12-29 | 2014-12-31 | 20,000 | $23.50 | $470.0K | 26,132 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2014-09-30 | 2014-10-02 | 63 | $66.34 | $4.2K | 1,199 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-08-18 | 2014-08-18 | 409 | $63.68 | $26.0K | 6,132 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-08-15 | 2014-08-18 | 1,250 | — | $0 | 2,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-08-15 | 2014-08-18 | 1,250 | — | $0 | 6,541 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2014-06-30 | 2014-07-02 | 82 | $69.82 | $5.7K | 1,136 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-05-14 | 2014-05-14 | 499 | $69.00 | $34.4K | 5,291 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-05-13 | 2014-05-14 | 1,500 | — | $0 | 3,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-05-13 | 2014-05-14 | 1,500 | — | $0 | 5,790 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-04-16 | 2014-04-16 | 441 | $64.00 | $28.2K | 4,290 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-04-15 | 2014-04-16 | 1,361 | — | $0 | 4,085 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-04-15 | 2014-04-16 | 1,361 | — | $0 | 4,731 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2014-03-31 | 2014-04-02 | 77 | $73.15 | $5.6K | 1,054 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-02-18 | 2014-02-19 | 555 | $75.00 | $41.6K | 3,370 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-02-16 | 2014-02-19 | 833 | — | $0 | 2,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-02-16 | 2014-02-19 | 833 | — | $0 | 3,925 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-02-15 | 2014-02-19 | 751 | — | $0 | 2,253 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-02-15 | 2014-02-19 | 751 | — | $0 | 3,092 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 4,029 | — | $0 | 4,029 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 4,365 | — | $0 | 4,365 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 31,559 | — | $0 | 31,559 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-09-30 | 2013-10-02 | 74 | $63.55 | $4.7K | 977 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-09-03 | 2013-09-05 | 400 | $64.08 | $25.6K | 2,341 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-08-15 | 2013-08-16 | 1,250 | — | $0 | 3,750 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-08-15 | 2013-08-16 | 1,250 | — | $0 | 2,741 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-06-28 | 2013-07-02 | 288 | $36.69 | $10.6K | 1,491 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-06-28 | 2013-07-02 | 114 | $48.29 | $5.5K | 903 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-14 | 2013-05-15 | 488 | $49.18 | $24.0K | 1,203 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-13 | 2013-05-15 | 1,500 | — | $0 | 4,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-13 | 2013-05-15 | 1,500 | — | $0 | 1,691 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-04-15 | 2013-04-16 | 17,233 | — | $0 | 17,233 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-04-15 | 2013-04-16 | 5,446 | — | $0 | 5,446 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-03-28 | 2013-04-02 | 108 | $46.82 | $5.1K | 789 | SEC↗ |